FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2551329042> ?p ?o ?g. }

• W2551329042 endingPage "92" @default.
• W2551329042 startingPage "88" @default.
• W2551329042 abstract "Background: Pazopanib is a multitargeted tyrosine kinase inhibitor approved for the treatment of patients with selective subtypes of advanced soft tissue sarcoma (STS) who have previously received standard chemotherapy including anthracyclines. Data on the efficacy in vascular sarcomas are limited. The main objective of this study was to investigate the activity of pazopanib in vascular sarcomas.Patients and methods: A retrospective study of patients with advanced vascular sarcomas, including angiosarcoma (AS), epithelioid hemangioendothelioma (HE) and intimal sarcoma (IS) treated with pazopanib in real life practice at EORTC centers as well as patients treated within the EORTC phase II and III clinical trials (62043/62072) was performed. Patient and tumor characteristics were collected. Response was assessed according to RECIST 1.1. and survival analysis was performed.Results: Fifty-two patients were identified, 40 (76.9%), 10 (19.2%) and two (3.8%) with AS, HE and IS, respectively. The response rate was eight (20%), two (20%) and two (100%) in the AS, HE and IS subtypes, respectively. There was no significant difference in response rate between cutaneous and non-cutaneous AS and similarly between radiation-associated and non-radiation-associated AS. Median progression-free survival (PFS) and median overall survival (OS; from commencing pazopanib) were three months (95% CI 2.1–4.4) and 9.9 months (95% CI 6.5–11.3) in AS, respectively.Conclusion: The activity of pazopanib in AS is comparable to its reported activity in other STS subtypes. In this study, the activity of pazopanib was similar in cutaneous/non-cutaneous and in radiation/non-radiation-associated AS. In addition, pazopanib showed promising activity in HE and IS, worthy of further evaluation." @default.
• W2551329042 created "2016-11-30" @default.
• W2551329042 creator A5003575711 @default.
• W2551329042 creator A5020899956 @default.
• W2551329042 creator A5025935523 @default.
• W2551329042 creator A5042679338 @default.
• W2551329042 creator A5047837719 @default.
• W2551329042 creator A5048969933 @default.
• W2551329042 creator A5050031420 @default.
• W2551329042 creator A5051744290 @default.
• W2551329042 creator A5057828080 @default.
• W2551329042 creator A5060954086 @default.
• W2551329042 creator A5061157288 @default.
• W2551329042 creator A5065856111 @default.
• W2551329042 creator A5066380305 @default.
• W2551329042 creator A5076043217 @default.
• W2551329042 creator A5088025233 @default.
• W2551329042 creator A5090575005 @default.
• W2551329042 creator A5091114658 @default.
• W2551329042 date "2016-11-14" @default.
• W2551329042 modified "2023-10-18" @default.
• W2551329042 title "Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis" @default.
• W2551329042 cites W1559201260 @default.
• W2551329042 cites W1568316544 @default.
• W2551329042 cites W1593875197 @default.
• W2551329042 cites W1919801711 @default.
• W2551329042 cites W1997194914 @default.
• W2551329042 cites W2003278910 @default.
• W2551329042 cites W2017230914 @default.
• W2551329042 cites W2020535613 @default.
• W2551329042 cites W2021087771 @default.
• W2551329042 cites W2033889480 @default.
• W2551329042 cites W2048513224 @default.
• W2551329042 cites W2088018126 @default.
• W2551329042 cites W2088074688 @default.
• W2551329042 cites W2096928109 @default.
• W2551329042 cites W2101776780 @default.
• W2551329042 cites W2107230638 @default.
• W2551329042 cites W2118880688 @default.
• W2551329042 cites W2124148984 @default.
• W2551329042 cites W2124255159 @default.
• W2551329042 cites W2141001525 @default.
• W2551329042 cites W2142170680 @default.
• W2551329042 cites W2144530818 @default.
• W2551329042 cites W2150461364 @default.
• W2551329042 cites W2168977372 @default.
• W2551329042 cites W2170973522 @default.
• W2551329042 doi "https://doi.org/10.1080/0284186x.2016.1234068" @default.
• W2551329042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27838944" @default.
• W2551329042 hasPublicationYear "2016" @default.
• W2551329042 type Work @default.
• W2551329042 sameAs 2551329042 @default.
• W2551329042 citedByCount "130" @default.
• W2551329042 countsByYear W25513290422017 @default.
• W2551329042 countsByYear W25513290422018 @default.
• W2551329042 countsByYear W25513290422019 @default.
• W2551329042 countsByYear W25513290422020 @default.
• W2551329042 countsByYear W25513290422021 @default.
• W2551329042 countsByYear W25513290422022 @default.
• W2551329042 countsByYear W25513290422023 @default.
• W2551329042 crossrefType "journal-article" @default.
• W2551329042 hasAuthorship W2551329042A5003575711 @default.
• W2551329042 hasAuthorship W2551329042A5020899956 @default.
• W2551329042 hasAuthorship W2551329042A5025935523 @default.
• W2551329042 hasAuthorship W2551329042A5042679338 @default.
• W2551329042 hasAuthorship W2551329042A5047837719 @default.
• W2551329042 hasAuthorship W2551329042A5048969933 @default.
• W2551329042 hasAuthorship W2551329042A5050031420 @default.
• W2551329042 hasAuthorship W2551329042A5051744290 @default.
• W2551329042 hasAuthorship W2551329042A5057828080 @default.
• W2551329042 hasAuthorship W2551329042A5060954086 @default.
• W2551329042 hasAuthorship W2551329042A5061157288 @default.
• W2551329042 hasAuthorship W2551329042A5065856111 @default.
• W2551329042 hasAuthorship W2551329042A5066380305 @default.
• W2551329042 hasAuthorship W2551329042A5076043217 @default.
• W2551329042 hasAuthorship W2551329042A5088025233 @default.
• W2551329042 hasAuthorship W2551329042A5090575005 @default.
• W2551329042 hasAuthorship W2551329042A5091114658 @default.
• W2551329042 hasBestOaLocation W25513290421 @default.
• W2551329042 hasConcept C121608353 @default.
• W2551329042 hasConcept C126322002 @default.
• W2551329042 hasConcept C141071460 @default.
• W2551329042 hasConcept C142724271 @default.
• W2551329042 hasConcept C143998085 @default.
• W2551329042 hasConcept C2778256501 @default.
• W2551329042 hasConcept C2778439243 @default.
• W2551329042 hasConcept C2778629024 @default.
• W2551329042 hasConcept C2778820342 @default.
• W2551329042 hasConcept C2779217266 @default.
• W2551329042 hasConcept C2779490328 @default.
• W2551329042 hasConcept C2910096961 @default.
• W2551329042 hasConcept C71924100 @default.
• W2551329042 hasConceptScore W2551329042C121608353 @default.
• W2551329042 hasConceptScore W2551329042C126322002 @default.
• W2551329042 hasConceptScore W2551329042C141071460 @default.
• W2551329042 hasConceptScore W2551329042C142724271 @default.
• W2551329042 hasConceptScore W2551329042C143998085 @default.
• W2551329042 hasConceptScore W2551329042C2778256501 @default.

• next